Risk-Adapted, Ofatumumab-Based Chemoimmunotherapy And Maintenance In Treatment-Naive Cll: A Phase Ii Study
Sanjal Desai, Dennis Drinkwater,Clifton Craig Mo,Mohammed Zh Farooqui,Susan Soto,Janet Valdez,Erika M Gaglione,Xin Tian,Pia Nierman,Jennifer Lotter,Gerald Marti,Cydney Nichols,Alankrita Taneja,Sarah E. M. Herman,Irina Maric,Laura M Wake,Maryalice Stetler-Stevenson,Constance M. Yuan, Tom Hughes,Margaret A. Lindorfer,Ronald P. Taylor,Adrian Wiestner,Inhye E Ahn BLOOD（2019）
AI 理解论文
溯源树
样例
